352 related articles for article (PubMed ID: 27613562)
21. Temporal trends in cardiovascular risk factors and performance of the Framingham Risk Score and the Pooled Cohort Equations.
Rospleszcz S; Thorand B; de Las Heras Gala T; Meisinger C; Holle R; Koenig W; Mansmann U; Peters A
J Epidemiol Community Health; 2019 Jan; 73(1):19-25. PubMed ID: 30262553
[TBL] [Abstract][Full Text] [Related]
22. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
Al-Shamsi S; Govender RD; King J
BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
[TBL] [Abstract][Full Text] [Related]
23. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
[TBL] [Abstract][Full Text] [Related]
24. Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.
De Socio GV; Pucci G; Baldelli F; Schillaci G
BMC Infect Dis; 2017 Jun; 17(1):414. PubMed ID: 28606059
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy.
Dam V; Onland-Moret NC; Verschuren WMM; Boer JMA; Benschop L; Franx A; Moons KGM; Boersma E; van der Schouw YT;
Heart; 2019 Feb; 105(4):330-336. PubMed ID: 30209122
[TBL] [Abstract][Full Text] [Related]
26. Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection.
Shaikh K; Bhondoekhan F; Haberlen S; Nakanishi R; Roy SK; Alla VM; Brown TT; Lee J; Osawa K; Almeida S; Rahmani S; Nezarat N; Sheidaee N; Kim M; Jayawardena E; Kim N; Hathiramani N; Palella FJ; Witt M; Ahmad K; Kingsley L; Post WS; Budoff MJ
AIDS; 2022 Feb; 36(2):215-224. PubMed ID: 34608042
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations.
Petoumenos K; Reiss P; Ryom L; Rickenbach M; Sabin CA; El-Sadr W; d'Arminio Monforte A; Phillips AN; De Wit S; Kirk O; Dabis F; Pradier C; Lundgren JD; Law MG;
HIV Med; 2014 Nov; 15(10):595-603. PubMed ID: 24840675
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.
Emdin CA; Khera AV; Natarajan P; Klarin D; Baber U; Mehran R; Rader DJ; Fuster V; Kathiresan S
Am J Cardiol; 2017 Mar; 119(6):881-885. PubMed ID: 28061997
[TBL] [Abstract][Full Text] [Related]
29. Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations.
Achhra AC; Lyass A; Borowsky L; Bogorodskaya M; Plutzky J; Massaro JM; D'Agostino RB; Triant VA
Curr HIV/AIDS Rep; 2021 Aug; 18(4):271-279. PubMed ID: 34247329
[TBL] [Abstract][Full Text] [Related]
30. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
31. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
Friis-Møller N; Thiébaut R; Reiss P; Weber R; Monforte AD; De Wit S; El-Sadr W; Fontas E; Worm S; Kirk O; Phillips A; Sabin CA; Lundgren JD; Law MG;
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):491-501. PubMed ID: 20543702
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.
Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; San RJ; Soriano V; Sánchez-Parra C; Sainz T; Fernández-Cruz A
Eur J Prev Cardiol; 2014 Jun; 21(6):739-48. PubMed ID: 22718798
[TBL] [Abstract][Full Text] [Related]
33. Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis.
Ungprasert P; Matteson EL; Crowson CS
Am J Cardiol; 2017 Sep; 120(5):868-873. PubMed ID: 28705378
[TBL] [Abstract][Full Text] [Related]
34. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
[TBL] [Abstract][Full Text] [Related]
35. Prediction of hard cardiovascular events in HIV patients.
Raggi P; De Francesco D; Manicardi M; Zona S; Bellasi A; Stentarelli C; Carli F; Beghetto B; Mussini C; Malagoli A; Guaraldi G
J Antimicrob Chemother; 2016 Dec; 71(12):3515-3518. PubMed ID: 27591294
[TBL] [Abstract][Full Text] [Related]
36. Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011.
Ou HT; Chang KC; Li CY; Yang CY; Ko NY
Int J Cardiol; 2017 Mar; 230():592-598. PubMed ID: 28062146
[TBL] [Abstract][Full Text] [Related]
37. Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year Study.
Kapelios CJ; Argyris AA; Protogerou AD; Katsarolis I; Arida A; Papadopoulou M; Ntaroutsou E; Kitas G; Sfikakis PP; Psichogiou M
J Acquir Immune Defic Syndr; 2020 Apr; 83(5):504-512. PubMed ID: 31923089
[TBL] [Abstract][Full Text] [Related]
38. Validation of the Framingham General Cardiovascular Risk Score and Pooled Cohort Equations in a Community-Based Population: A Prospective Cohort Study Analysis 2006-2017.
Jian JZ; Tzeng IS; Hsieh CF; Huang HL; Chen CL; Liu KL
Acta Cardiol Sin; 2023 Nov; 39(6):879-887. PubMed ID: 38022424
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular disease risk among transgender women living with HIV in the United States.
Gosiker BJ; Lesko CR; Rich AJ; Crane HM; Kitahata MM; Reisner SL; Mayer KH; Fredericksen RJ; Chander G; Mathews WC; Poteat TC
PLoS One; 2020; 15(7):e0236177. PubMed ID: 32687532
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
